Evidence map›Paper›PMID 32434941›Full record

Trial reportJournal of immunology (Baltimore, Md. : 1950)2020

Opsonization-Enhanced Antigen Presentation by MR1 Activates Rapid Polyfunctional MAIT Cell Responses Acting as an Effector Arm of Humoral Antibacterial Immunity.

Caroline Boulouis, Jean-Baptiste Gorin, Joana Dias, Peter Bergman, Edwin Leeansyah, Johan K Sandberg

Open access · greenAbstract readClinical Trial, Phase II
In one paragraph

Trial report in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Human MAIT cell response profiles biased toward IL-17 or IL-10 are distinct effector states directed by the cytokine milieu.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
  4. Article
  5. Mucosa-Associated Invariant T Cell Hypersensitivity toJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Caroline BoulouisCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, 14152 Stockholm, Sweden.ORCID 0000-0003-0562-5395
Jean-Baptiste GorinCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, 14152 Stockholm, Sweden.
Joana DiasCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, 14152 Stockholm, Sweden.
Peter BergmanDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14152 Stockholm, Sweden.ORCID 0000-0003-3306-3713
Edwin LeeansyahCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, 14152 Stockholm, Sweden.ORCID 0000-0003-0505-4967
Johan K SandbergCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, 14152 Stockholm, Sweden; johan.sandberg@ki.se.ORCID 0000-0002-6275-0750
Karolinska Institutet · SEKarolinska University Hospital · SENational University of Singapore · SG

Funding

Intestinal MAIT Cells in HIV InfectionR01DK108350 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PAQUIN-PROULX, DOMINIC, SANDBERG, JOHAN K · 2015 to 2019
$2.5M
NIDDK NIH HHS R01 DK108350
6 · The paper itself

Abstract

Mucosa-associated invariant T (MAIT) cells are innate-like antimicrobial T cells recognizing a breadth of important pathogens via presentation of microbial riboflavin metabolite Ags by MHC class Ib-related (MR1) molecules. However, the interaction of human MAIT cells with adaptive immune responses and the role they may play in settings of vaccinology remain relatively little explored. In this study we investigated the interplay between MAIT cell-mediated antibacterial effector functions and the humoral immune response. IgG opsonization of the model microbe

Indexed as

Antigen PresentationAdultAntibodies, BacterialAntigens, BacterialEscherichia coliEscherichia coli InfectionsFemaleHistocompatibility Antigens Class IHumansImmunity, HumoralImmunogenicity, VaccineLymphocyte ActivationMaleMiddle AgedMinor Histocompatibility AntigensMucosal-Associated Invariant T Cells13-valent pneumococcal vaccineAntibodies, BacterialAntigens, BacterialHistocompatibility Antigens Class IMinor Histocompatibility AntigensMR1 protein, humanPneumococcal Vaccines

Identifiers

PMID32434941
PMCPMC7311261
OpenAlexW3027386645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.